New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type | Version: 0.1.0 | |||
Active as of 2024-07-21 | Computable Name: canshare-sact-cancer-type | |||
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-sact-cancer-type |
The type of primary cancer being assessed, by systemic anti-cancer therapy (SACT).
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-sact-cancer-type
version: versionId: id (PrimitiveType/ValueSet.meta.versionId): native = id -> 1; Last updated: 2024-07-25 17:29:15+1200; Language: en-x-sctlang-23162100-0210105
This value set includes codes based on the following rules:
http://snomed.info/sct
where constraint = (^297871000210108 |New Zealand cancer type reference set| MINUS (93725000 |Bone primary| OR 94087009 |Testis primary| OR 301001000210106 |Testicular adnexa| OR 371971003 |Uterine corpus primary| OR 350761000210108 |Uterine ligament primary| OR 372024009 |Uterine cervix primary| OR 93689003 |Urinary bladder primary| OR 371986009 |Eye primary| OR 301051000210107 |Renal pelvis and/or ureter primary| OR ^302661000210109 |New Zealand cancer neuroendocrine cancer type reference set| OR 351591000210100 |Myeloid neoplasm| OR 445105005 |Blastic plasmacytoid dendritic cell neoplasm| OR 298491000210105 |B-cell lymphoid neoplasm| OR 351661000210109 |Aggressive non-hodgkin B cell lymphoma| OR 400122007 |Primary cutaneous T cell lymphoma| OR 414166008 |Extranodal NK/T-cell lymphoma| OR 422172005 |T/NK-cell neoplasm| OR 109993000 |Myeloproliferative neoplasm| OR 351651000210106 |Indolent non-Hodgkin B cell lymphoma| OR 414653009 |Mastocytosis| OR 445738007 |Myelodysplastic-myeloproliferative neoplasm| OR 737224006 |Histiocytic and dendritic cell neoplasm| OR 351671000210103 |Plasma cell disorder| OR 109977009 |Peripheral T-cell lymphoma| OR 421418009| Mature T/NK-cell neoplasm| OR ^302921000210105 |New Zealand cancer soft tissue cancer type reference set| OR 1287197000 |Thymus neuroendocrine tumour (NET) primary| OR 226521000119108 |Nasopharynx primary| OR ^ 302931000210107 |New Zealand cancer skin cancer type reference set| OR 298821000210105 |Head and neck tumour of unknown primary| OR 93659005 |Paranasal sinus primary| OR 93917007 |Nasal cavity primary| OR 372001002 |Oral cavity primary | OR 298811000210100 |Oropharynx and hypopharynx primary| OR 94098005 |Thyroid gland primary| OR 372123001 |Skin of head and neck primary| OR 351691000210104 |Chronic lymphocytic leukaemia and/or small lymphocytic lymphoma| OR ^302951000210101 |New Zealand cancer thoracic cancer type reference set|)) OR 1287197000 |Thymus neuroendocrine tumour (NET) primary| OR 109915008 |Meninges primary| OR 94098005 |Thyroid gland primary| OR 1268348008 |Lung small cell carcinoma primary| OR 1259727001 |Lung non-small cell carcinoma primary| OR 94096009 |Thymus primary|http://snomed.info/sct
Code | Display |
1290015006 | Stomach neuroendocrine tumour (NET) primary |
1287667007 | Small intestine neuroendocrine tumour (NET) primary |
1287196009 | Appendix neuroendocrine tumour (NET) primary |
1290013004 | Anus neuroendocrine tumour (NET) primary |
1287665004 | Pancreas neuroendocrine tumour (NET) primary |
1290021005 | Lung neuroendocrine tumor (NET) primary |
109993000 | Other myeloproliferative neoplasm (MPN) |
351651000210106 | Other indolent B cell lymphoma |
298161000210105 | Other thoracic primary |
414653009 | Other mastocytosis |
445738007 | Other myelodysplastic-myeloproliferative neoplasm |
737224006 | Other histiocytic and dendritic cell neoplasm |
351671000210103 | Other plasma cell disorder |
109977009 | Other peripheral T-cell lymphoma |
93764002 | Conjunctiva primary |
93987004 | Retina primary |
94128004 | Uveal tract primary |
93998003 | Sclera primary |
93931007 | Optic nerve primary |
371993008 | Lacrimal gland primary |
423195009 | Lacrimal drainage system primary |
93932000 | Orbit primary |
1287197000 | Thymus neuroendocrine tumour (NET) primary |
93723007 | Skull and facial bone primary |
372028007 | Vertebral column primary |
372115003 | Pelvic bone primary |
94063007 | Trunk soft tissue primary |
94062002 | Thoracic soft tissue primary |
298221000210106 | Other neuroendocrine primary |
297901000210108 | Other gastrointestinal primary |
226521000119108 | Nasopharynx primary |
93933005 | Oropharynx primary |
93831006 | Hypopharynx primary |
94104001 | Trachea primary |
297921000210100 | Other head and neck primary |
93845000 | Odontogenic primary |
298231000210108 | Other endocrine primary |
94047004 | Other skin primary |
298931000210104 | Squamous cell carcinoma of skin primary |
402536001 | Basal cell carcinoma of skin primary |
298921000210101 | Merkel cell carcinoma of skin primary |
1268881002 | Melanoma of skin primary |
301051000210107 | Renal pelvis and ureter primary |
351691000210104 | Chronic lymphocytic leukaemia and small lymphocytic lymphoma |
1197332003 | Melanoma CNS primary |
93880001 | Other lung primary |
93689003 | Bladder primary |
372024009 | Cervix uterine primary |
93744007 | Other CNS primary |
93885006 | Other male genital primary |
94125001 | Other urinary system primary |
297911000210105 | Other gynaecological primary |
93725000 | Other bone primary |
372010005 | Other soft tissue primary |
http://canshare.co.nz/fhir/CodeSystem/snomed-unpublished
Code | Display |
476501000210108 | Testicular other primary |
476511000210105 | Testicular seminoma primary |
476521000210100 | Testicular non-seminoma primary |
476481000210100 | Uterine primary |
382691000210103 | CNS nerve primary |
390801000210106 | Colorectal neuroendocrine tumour (NET) primary |
390811000210108 | Hepatic neuroendocrine tumour (NET) primary |
390821000210103 | Urinary system neuroendocrine tumour (NET) primary |
390831000210101 | Male genital neuroendocrine tumour (NET) primary |
390841000210109 | Gynaecological neuroendocrine tumour (NET) primary |
390851000210107 | Breast neuroendocrine tumour (NET) primary |
390861000210105 | Head and neck neuroendocrine tumour (NET) primary |
390991000210105 | Pituitary neuroendocrine tumour (PitNET) primary |
390871000210104 | CNS neuroendocrine tumour (NET) primary |
390901000210104 | Eyelid primary |
392071000210106 | Plasmacytoid dendritic cell neoplasm |
392081000210108 | Other B-cell lymphoid proliferation |
392031000210109 | Other aggressive B cell lymphoma |
392161000210104 | Mature T/NK-cell leukaemia |
392201000210106 | Primary cutaneous T cell lymphoproliferative disorder |
392211000210108 | Intestinal T/NK-cell lymphoid proliferation |
392221000210103 | EBV-positive T/NK-cell lymphoid proliferation |
392121000210106 | Other T-cell lymphoid proliferation |
390881000210102 | Other eye and orbit primary |
398111000210103 | Appendicular skeleton primary |
398121000210108 | Thoracic bone primary |
398131000210105 | Skin soft tissue primary |
398141000210102 | Head and neck soft tissue primary |
398161000210101 | Extremity soft tissue primary |
398201000210108 | Abdomen and pelvis soft tissue primary |
398231000210103 | Retroperitoneal soft tissue primary |
398241000210106 | CNS soft tissue primary |
398251000210109 | Eye and orbit soft tissue primary |
448081000210107 | Parapharyngeal space primary |
448091000210109 | Unknown primary tumour of head and neck |
448031000210108 | Oral cavity and mobile tongue primary |
448051000210102 | Nasal cavity and paranasal sinus primary |
448061000210104 | Ear primary |
392141000210100 | Other mature T/NK-cell lymphoid proliferation |
448111000210100 | Other non-cutaneous melanoma primary |
382551000210106 | Other neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary |
382561000210109 | Other neuroendocrine tumour non-gastroenteropancreatic (non-GEP NET) primary |
No Expansion for this valueset (Unsupported Code System Version)
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |